SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Eli Lilly and Company and Boehringer Ingelheim Corporation Announce Strategic Alliance to Bring New Diabetes Treatments to Patients Worldwide; Boehringer Ingelheim to Get 300M Euro; up to a Total of 625M Euro